CLINDA-DERM Drug Patent Profile
✉ Email this page to a colleague
When do Clinda-derm patents expire, and what generic alternatives are available?
Clinda-derm is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in CLINDA-DERM is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clinda-derm
A generic version of CLINDA-DERM was approved as clindamycin phosphate by ALMAJECT on July 24th, 1987.
Summary for CLINDA-DERM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 1 |
Patent Applications: | 2,341 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CLINDA-DERM at DailyMed |
Recent Clinical Trials for CLINDA-DERM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for CLINDA-DERM
US Patents and Regulatory Information for CLINDA-DERM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Us | CLINDA-DERM | clindamycin phosphate | SOLUTION;TOPICAL | 063329-001 | Sep 30, 1992 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |